Qube Research & Technologies Ltd - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 72 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$87,000
+67.3%
73,421
-10.4%
0.00%
Q2 2022$52,000
-34.2%
81,968
+209.7%
0.00%
-100.0%
Q2 2021$79,000
+27.4%
26,469
-9.0%
0.00%0.0%
Q4 2020$62,000
-56.0%
29,087
-75.9%
0.00%
-50.0%
Q3 2020$141,000
+513.0%
120,868
+383.3%
0.00%
Q2 2020$23,00025,0080.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders